Biotech · Private company
Elixirgen Therapeutics, Inc.
Track this companyFree. Adds Elixirgen Therapeutics, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials22 recruiting or active
Pipeline programs2From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline2
- EXG34217Phase 1 · Telomere Biology Disorders With Bone Marrow FailureClinicalTrials.gov · fetched Nov 12, 2026
- EXG34217Phase 1 · Telomere ShorteningClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials2
- Rollover Study From EXG-US-01PHASE1 · ENROLLING_BY_INVITATION · started Jan 1, 2024ClinicalTrials.gov NCT05868499 · fetched Nov 12, 2026
- Study to Evaluate of EXG34217 in Patients With Telomere Biology Disorders With Bone Marrow FailurePHASE1 · ACTIVE_NOT_RECRUITING · started Apr 8, 2021ClinicalTrials.gov NCT04211714 · fetched Nov 12, 2026